Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3666 Target Snapshot

5-hydroxytryptamine receptor 3A · SINGLE PROTEIN · Cavia porcellus

146Compounds
33Assays
2Approved Drugs
92.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt O70212. Use UniProt O70212 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O70212 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats 5-hydroxytryptamine receptor 3A as ChEMBL target CHEMBL3666, mapped to UniProt O70212. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
5-hydroxytryptamine receptor 3A
SINGLE PROTEIN · Cavia porcellus
As of 2026-09-13
ChEMBL target ID
CHEMBL3666
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
O70212
5-hydroxytryptamine receptor 3A
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether 5-hydroxytryptamine receptor 3A is the right protein anchor across sources, using UniProt O70212 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label5-hydroxytryptamine receptor 3A
UniProt AccessionO70212
Component TypeProtein
Sequence Length490 aa

5-hydroxytryptamine receptor 3A

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as 5-hydroxytryptamine receptor 3A, mapped to UniProt O70212. Sequence length is 490 aa.

Mapped IDO70212
Review name5-hydroxytryptamine receptor 3A
OrganismCavia porcellus
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase III
Assay Mix

Activity Type Distribution

IC5020.0
KI1.0
EC503.0
KD68.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL289469 8.4 Ki 3.981 Approved
CHEMBL4228145 7.8 Kd 15.85 Preclinical
CHEMBL4225725 7.7 Kd 19.95 Preclinical
CHEMBL1668031 7.7 Kd 19.95 Preclinical
CHEMBL1269981 7.6 Kd 25.12 Preclinical
CHEMBL56564 7.52 Kd 30.2 Clinical
CHEMBL1668032 7.5 Kd 31.62 Preclinical
CHEMBL4225302 7.4 Kd 39.81 Preclinical
CHEMBL184379 7.4 Kd 39.81 Preclinical
CHEMBL4227570 7.3 Kd 50.12 Preclinical
Distribution

pChEMBL Value Distribution

8
5.0
9
5.5
8
6.0
12
6.5
9
7.0
8
7.5
1
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

GRANISETRON
CHEMBL289469
Approved 1993
ONDANSETRON
CHEMBL46
Approved 1991
Assay Landscape

Assay Landscape

33
Total Assays
48
Tested Compounds
2
Assay Types
Binding — 20 assays, 27 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 17 21 6.3
single protein format 2 1 7.5
assay format 1 5 7.6
Functional — 13 assays, 48 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 13 48 5.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine